1. Home
  2. APTV vs VTRS Comparison

APTV vs VTRS Comparison

Compare APTV & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APTV
  • VTRS
  • Stock Information
  • Founded
  • APTV 2011
  • VTRS 1961
  • Country
  • APTV Switzerland
  • VTRS United States
  • Employees
  • APTV N/A
  • VTRS N/A
  • Industry
  • APTV Auto Parts:O.E.M.
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • APTV Consumer Discretionary
  • VTRS Health Care
  • Exchange
  • APTV Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • APTV 14.1B
  • VTRS 13.5B
  • IPO Year
  • APTV 1999
  • VTRS N/A
  • Fundamental
  • Price
  • APTV $61.80
  • VTRS $11.33
  • Analyst Decision
  • APTV Buy
  • VTRS Hold
  • Analyst Count
  • APTV 17
  • VTRS 3
  • Target Price
  • APTV $84.00
  • VTRS $13.67
  • AVG Volume (30 Days)
  • APTV 3.5M
  • VTRS 10.6M
  • Earning Date
  • APTV 02-06-2025
  • VTRS 02-26-2025
  • Dividend Yield
  • APTV N/A
  • VTRS 4.23%
  • EPS Growth
  • APTV 11.88
  • VTRS N/A
  • EPS
  • APTV 9.04
  • VTRS N/A
  • Revenue
  • APTV $19,725,000,000.00
  • VTRS $15,048,500,000.00
  • Revenue This Year
  • APTV $0.20
  • VTRS N/A
  • Revenue Next Year
  • APTV $2.69
  • VTRS N/A
  • P/E Ratio
  • APTV $6.83
  • VTRS N/A
  • Revenue Growth
  • APTV N/A
  • VTRS N/A
  • 52 Week Low
  • APTV $51.47
  • VTRS $9.93
  • 52 Week High
  • APTV $88.89
  • VTRS $13.62
  • Technical
  • Relative Strength Index (RSI)
  • APTV 60.43
  • VTRS 29.34
  • Support Level
  • APTV $60.26
  • VTRS $11.13
  • Resistance Level
  • APTV $62.09
  • VTRS $11.48
  • Average True Range (ATR)
  • APTV 1.37
  • VTRS 0.31
  • MACD
  • APTV 0.06
  • VTRS -0.08
  • Stochastic Oscillator
  • APTV 69.78
  • VTRS 13.61

About APTV Aptiv PLC

Aptiv Holdings Ltd, formerly Aptiv PLC signal and power solutions segment supplies components and systems that make up a vehicle's electrical system, including wiring assemblies and harnesses, connectors, electrical centers, and hybrid electrical systems. The safety and user experience segment provides body controls, infotainment and connectivity systems, passive and active safety electronics, driver-assist technologies, and displays, as well as the development of software for these systems.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: